Skip to main content
. 2012 Oct 1;11(2):146–163. doi: 10.1111/mcn.12006

Table 6.

Measure of compliance by women's reports, by group and centre

Subsequent visit after enrolment All 1o de Maio study centre Machava study centre
n = 4326 n = 2749 n = 1577
Selective iron* Routine iron Selective iron* Routine iron Selective iron* Routine iron
n = 2142 n = 2184 n = 1366 n = 1383 n = 776 n = 801
First subsequent visit, n (%) 1455 (68) 1494 (68) 938 (69) 965 (70) 517 (67) 529 (66)
Tablets taken during the past week, n (%) §
Regularly 1344 (92) 1380 (92) 883 (94) 912 (95) 461 (89) 468 (88)
Sometimes 90 (6) 88 (6) 42 (4) 35 (4) 48 (9) 53 (10)
No 15 (1) 20 (1) 7 (1) 14 (1) 8 (2) 6 (1)
Second subsequent visit, n (%) 1040 (49) 1106 (51) 618 (45) 677 (49) 422 (54) 429 (54)
Tablets taken during the past week, n (%) §
Regularly 962 (93) 1031 (93) 588 (95) 652 (96) 374 (87) 379 (88)
Sometimes 70 (7) 60 (5) 24 (4) 15 (2) 46 (11) 45 (10)
No 5 (0.5) 8 (0.7) 4 (0.6) 7 (1) 1 (0.2) 1 (0.2)
Third subsequent visit, n (%) 694 (33) 720 (33) 398 (29) 412 (30) 296 (38) 308 (38)
Tablets taken during the past week, n (%) §
Regularly 647 (93) 670 (93) 381 (96) 402 (98) 266 (90) 268 (87)
Sometimes 43 (6) 46 (6) 15 (4) 7 (2) 28 (9) 39 (13)
No 3 (0.4) 3 (0.4) 2 (0.5) 2 (0.5) 1 (0.3) 1 (0.3)

*Daily intake of 400 μg of folic acid and received iron (120 mg) if their haemoglobin was <9 g/dL. Daily intake of 60 mg of ferrous sulphate plus 400 μg of folic acid. Frequency and percentage of women at recruitment who attended subsequent visits. §The denominator is the number of those who attended at each subsequent visit.